Clinical Trial Update: A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effectiveness of Irosustat added to an aromatase inhibitor in ER-positive locally advanced or metastatic breast cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Irosustat (irosustat)

Snippet

Sponsor: Imperial College London | Conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: COMPLETED